Last Posted: Nov 15, 2018
- Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multi-center COGENT Study.
Beri Nina et al. Clinical genetics 2018 Nov - Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report.
Andersson Evelyn et al. Molecular psychiatry 2018 Nov - Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
Chang Donald D et al. Pharmacogenomics 2018 Nov 19(16) 1269-1284 - Using genetics to understand the causal influence of higher BMI on depression.
Tyrrell Jessica et al. International journal of epidemiology 2018 Nov - Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder.
Groessl Erik J et al. Journal of managed care & specialty pharmacy 2018 Aug 24(8) 726-734 - Impacts for Children Living with Genetic Muscle Disorders and their Parents - Findings from a Population-Based Study.
Jones Kelly M et al. Journal of neuromuscular diseases 5(3) 341-352 - Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
Marshe Victoria S et al. Journal of neural transmission (Vienna, Austria : 1996) 2018 Oct - Novel genome-wide associations for suicidality in UK Biobank, genetic correlation with psychiatric disorders and polygenic association with completed suicide.
RJ Strawbridge et al, BIORXIV, October 25, 2018 - Pharmacogenomics: What does it mean for your health
CDC, October 2018 - Using Bayesian methodology to explore the profile of mental health and well-being in 646 mothers of children with 13 rare genetic syndromes in relation to mothers of children with autism.
Adams Dawn et al. Orphanet journal of rare diseases 2018 Oct 13(1) 185
.png)
No hay comentarios:
Publicar un comentario